These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 11593642

  • 1. Killing effect of interleukin-2 and interferon-alpha activated leukemic bone marrow in remission on K562 leukemic cells.
    Li C, Yan W, Hao Y, Han M, Qiu L, Liu H, Han J, Li X, Feng S.
    Chin Med J (Engl); 1999 Jan; 112(1):53-5. PubMed ID: 11593642
    [Abstract] [Full Text] [Related]

  • 2. [The killing effect of IL-2 and IFN-alpha activated bone marrow on K562 leukemic cell].
    Li C, Yan W, Hao Y, Feng S, Qiu L, Liu H, Han J, Li X, Feng S.
    Zhonghua Xue Ye Xue Za Zhi; 1997 Aug; 18(8):410-2. PubMed ID: 15625846
    [Abstract] [Full Text] [Related]

  • 3. [Comparative study on the lysis of leukemia cells by IL-2 activated bone marrow and cord blood].
    Shi X, Yu Z, Ma R.
    Zhonghua Xue Ye Xue Za Zhi; 1997 Aug; 18(8):417-21. PubMed ID: 15625848
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cytokine treatment of human bone marrow activates anti-leukaemia effector cells: monitoring of purging by polymerase chain reaction and DNA analysis.
    Dickinson AM, Middleton SL, Latham J, Dunn J, Thomas L, Proctor SJ.
    Leukemia; 1995 Mar; 9(3):444-9. PubMed ID: 7533866
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Interleukin-2 activation of human bone marrow in long-term cultures: an effective strategy for purging and generation of anti-tumor cytotoxic effectors.
    Verma UN, Bagg A, Brown E, Mazumder A.
    Bone Marrow Transplant; 1994 Feb; 13(2):115-23. PubMed ID: 8205079
    [Abstract] [Full Text] [Related]

  • 16. [In vitro inducing differentiation of bone marrow mononuclear cells of chronic myeloid leukemia].
    Wu CY, Zhang LS, Zhang YF, Chai Y, Yi LC, Song FX.
    Ai Zheng; 2005 Apr; 24(4):425-31. PubMed ID: 15820064
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Induction of graft versus leukemia effect in bone marrow transplantation: dosage and time schedule dependency of interleukin 2 therapy.
    Charak BS, Brynes RK, Katsuda S, Groshen S, Chen SC, Mazumder A.
    Cancer Res; 1991 Apr 15; 51(8):2015-20. PubMed ID: 2009520
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.